Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangjing Zhongyu Decoction is a traditional Chinese medicine (TCM) formula originally recorded in the Qing Dynasty text *Fu Qing Zhu Nu Ke* (Fu Qing-zhu's Gynecology). It is primarily used to treat female infertility associated with Kidney-yin deficiency and Blood deficiency. The classic formulation consists of four herbs: *Rehmannia glutinosa* (Shu Di Huang), *Angelica sinensis* (Dang Gui), *Paeonia lactiflora* (Bai Shao), and *Cornus officinalis* (Shan Zhu Yu). In modern clinical practice, it is frequently investigated for its potential to improve endometrial receptivity, enhance ovarian function, and support reproductive outcomes in conditions such as endometriosis-associated infertility, diminished ovarian reserve (DOR), and polycystic ovary syndrome (PCOS), particularly in patients undergoing assisted reproductive technologies like IVF/ICSI.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yangjing Zhongyu Decoction.